How much funding has Alchemab Therapeutics raised?

Alchemab Therapeutics has raised $82.0M in total funding, most recently a series a round.

When was Alchemab Therapeutics founded?

Alchemab Therapeutics was founded in 2019.

Where is Alchemab Therapeutics headquartered?

Alchemab Therapeutics is headquartered in London, United Kingdom.

What industry is Alchemab Therapeutics in?

Alchemab Therapeutics operates in Biotech.

How many employees does Alchemab Therapeutics have?

Alchemab Therapeutics has 11-50 employees.

Alchemab Therapeutics

Harnessing the Power of the Immune System

London, United Kingdom · Founded 2019 · $82.0M raised

Biotech

Headquarters: London
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: alchemab.com
Total Funding: $82.0M
Last Round: $82.0M Series AApr 2021
Rounds: 1

About

Biotech company harnessing the immune systems of disease-resilient individuals to develop protective antibody therapeutics for neurodegenerative diseases and oncology.

Summary

Alchemab Therapeutics is a Biotech company based in London, United Kingdom, founded in 2019. It has raised $82.0M in total across 1 round, most recently a $82.0M Series A round in Apr 2021.

LinkedIn X (Twitter)